OLMA   $14.91  -4.48% Market Closed After Close 14.81 -0.67%

Olema Pharmaceuticals, Inc.
Total Cash 239.10M
totalCashPerShare 4.178
EBITDA -122.27M
Total Debt 1.96M
quickRatio 9.042
currentRatio 9.127
Total Revenue
debtToEquity 0.864
Revenue/Share
ROA -0.35467
ROE -0.564
grossProfits
freeCashflow -44.97M
operatingCashflow -92.27M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 453.00M
forwardPE -4.742424
floatShares 29.25M
sharesOutstanding 57.27M
sharesShort 8.50M
sharesShortPriorMonth 8.83M
dateShortInterest
sharesPercentSharesOut 0.15%
heldPercentInsiders 0.04%
heldPercentInstitutions 1.01%
Short Ratio help_outline 16.23%
shortPercentOfFloat 0.26%
impliedSharesOutstanding
bookValue 3.971
Price To Book help_outline 3.15
earningsQuarterlyGrowth
netIncomeToCommon -109.63M
trailingEps -2.04%
forwardEps -2.64%
enterpriseToEbitda -3.71
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.58 3Q 2024
institutionsCount 189
lastUpdated Nov. 7, 2024, 3:29 a.m.